{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:53:39Z","timestamp":1791827619424,"version":"4.3.4"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"DOI":"10.1038\/s41584-026-01439-6","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:01:44Z","timestamp":1791824504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trained immunity in chronic, relapsing and low-grade joint inflammation"],"prefix":"10.1038","author":[{"given":"Brenda","family":"Kischkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-8309","authenticated-orcid":false,"given":"Sonia","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-9830","authenticated-orcid":false,"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2393-7475","authenticated-orcid":false,"given":"Hang Korng","family":"Ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"1439_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tvjl.2007.08.013","volume":"179","author":"S Sutton","year":"2009","unstructured":"Sutton, S. et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet. J. 179, 10\u201324 (2009).","journal-title":"Vet. J."},{"key":"1439_CR2","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","volume":"55","author":"S Alivernini","year":"2022","unstructured":"Alivernini, S., Firestein, G. S. & McInnes, I. B. The pathogenesis of rheumatoid arthritis. Immunity 55, 2255\u20132270 (2022).","journal-title":"Immunity"},{"key":"1439_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth, N. et al. Gout. Nat. Rev. Dis. Primers\u00a05, 69 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1439_CR4","first-page":"2109325","volume":"2020","author":"X Dai","year":"2020","unstructured":"Dai, X. et al. Disease-specific autoantibodies induce trained immunity in RA synovial tissues and its gene signature correlates with the response to clinical therapy. Mediators Inflamm. 2020, 2109325 (2020).","journal-title":"Mediators Inflamm."},{"key":"1439_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13075-021-02580-1","volume":"23","author":"M Badii","year":"2021","unstructured":"Badii, M. et al. Urate-induced epigenetic modifications in myeloid cells. Arthr. Res. Ther. 23, 202 (2021).","journal-title":"Arthr. Res. Ther."},{"key":"1439_CR6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","volume":"185","author":"X Li","year":"2022","unstructured":"Li, X. et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell 185, 1709\u20131727.e18 (2022).","journal-title":"Cell"},{"key":"1439_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147\u2013161.e12 (2018).","journal-title":"Cell"},{"key":"1439_CR8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176\u2013190.e19 (2018).","journal-title":"Cell"},{"key":"1439_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.13326","volume":"323","author":"P Vuscan","year":"2024","unstructured":"Vuscan, P., Kischkel, B., Joosten, L. A. B. & Netea, M. G. Trained immunity: general and emerging concepts. Immunol. Rev. 323, 164\u2013185 (2024).","journal-title":"Immunol. Rev."},{"key":"1439_CR10","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2017","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2017).","journal-title":"Science"},{"key":"1439_CR11","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","volume":"186","author":"JG Cheong","year":"2023","unstructured":"Cheong, J. G. et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell 186, 3882\u20133902.e24 (2023).","journal-title":"Cell"},{"key":"1439_CR12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J. Innate Immun. 6, 152\u2013158 (2014).","journal-title":"J. Innate Immun."},{"key":"1439_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41422-025-01171-y","volume":"35","author":"T Schl\u00fcter","year":"2025","unstructured":"Schl\u00fcter, T., van Elsas, Y., Priem, B., Ziogas, A. & Netea, M. G. Trained immunity: induction of an inflammatory memory in disease. Cell Res. 35, 792\u2013802 (2025).","journal-title":"Cell Res."},{"key":"1439_CR14","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ard.2025.03.016","volume":"84","author":"AM Marzeda","year":"2025","unstructured":"Marzeda, A. M. et al. Investigating endogenous immune-mediated monocyte memory in rheumatoid arthritis. Ann. Rheum. Dis. 84, 1484\u20131500 (2025).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR15","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.4049\/jimmunol.1701756","volume":"200","author":"Q Zhong","year":"2018","unstructured":"Zhong, Q. et al. IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in rheumatoid arthritis. J. Immunol. 200, 3913\u20133925 (2018).","journal-title":"J. Immunol."},{"key":"1439_CR16","first-page":"314154","volume":"9","author":"CH Gao","year":"2018","unstructured":"Gao, C. H., Dong, H. L., Tai, L. & Gao, X. M. Lactoferrin-containing immunocomplexes drive the conversion of human macrophages from M2- into M1-like phenotype. Front. Immunol. 9, 314154 (2018).","journal-title":"Front. Immunol."},{"key":"1439_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04275-7","volume":"7","author":"L Hu","year":"2017","unstructured":"Hu, L. et al. Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages. Sci. Rep. 7, 4230 (2017).","journal-title":"Sci. Rep."},{"key":"1439_CR18","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre, U. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791\u20131802 (2012).","journal-title":"J. Clin. Invest."},{"key":"1439_CR19","doi-asserted-by":"crossref","first-page":"53\u201362","DOI":"10.1002\/art.30081","volume":"63","author":"J Sokolove","year":"2011","unstructured":"Sokolove, J., Zhao, X., Chandra, P. E. & Robinson, W. H. Immune complexes containing citrullinated fibrinogen co-stimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor. Arthr. Rheum. 63, 53\u201362 (2011).","journal-title":"Arthr. Rheum."},{"key":"1439_CR20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen, M. M. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthr. Rheum. 50, 380\u2013386 (2004).","journal-title":"Arthr. Rheum."},{"key":"1439_CR21","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.174.8.5016","volume":"174","author":"R Liu-Bryan","year":"2005","unstructured":"Liu-Bryan, R., Pritzker, K., Firestein, G. S. & Terkeltaub, R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J. Immunol. 174, 5016\u20135023 (2005).","journal-title":"J. Immunol."},{"key":"1439_CR22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.joca.2023.04.011","volume":"31","author":"V Kl\u00fcck","year":"2023","unstructured":"Kl\u00fcck, V. et al. A functional genomics approach reveals suggestive quantitative trait loci associated with combined TLR4 and BCP crystal-induced inflammation and osteoarthritis. Osteoarthr. Cartil. 31, 1022\u20131034 (2023).","journal-title":"Osteoarthr. Cartil."},{"key":"1439_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/gucdd3020007","volume":"3","author":"M Zangari","year":"2025","unstructured":"Zangari, M. et al. Comparison of pathophysiological mechanisms among crystal-induced arthropathies. Gout Urate Cryst. Depos. Dis. 3, 7(2025).","journal-title":"Gout Urate Cryst. Depos. Dis."},{"key":"1439_CR24","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.3389\/fimmu.2018.02248","volume":"9","author":"L Campillo-Gimenez","year":"2018","unstructured":"Campillo-Gimenez, L. et al. Inflammatory potential of four different phases of calcium pyrophosphate relies on NF-\u03baB activation and MAPK pathways. Front. Immunol. 9, 2248 (2018).","journal-title":"Front. Immunol."},{"key":"1439_CR25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/annrheumdis-2020-217342","volume":"79","author":"F Renaudin","year":"2020","unstructured":"Renaudin, F. et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1\u03b2 activation on macrophages. Ann. Rheum. Dis. 79, 1506\u20131514 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR26","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LAB Joosten","year":"2010","unstructured":"Joosten, L. A. B. et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthr. Rheum. 62, 3237\u20133248 (2010).","journal-title":"Arthr. Rheum."},{"key":"1439_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"1439_CR28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.stemcr.2024.09.004","volume":"19","author":"D Flores-Gomez","year":"2024","unstructured":"Flores-Gomez, D. et al. Interleukin-1\u03b2 induces trained innate immunity in human hematopoietic progenitor cells in vitro. Stem Cell Rep. 19, 1651\u20131664 (2024).","journal-title":"Stem Cell Rep."},{"key":"1439_CR29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJW Arts","year":"2016","unstructured":"Arts, R. J. W. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807\u2013819 (2016).","journal-title":"Cell Metab."},{"key":"1439_CR30","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C. et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).","journal-title":"Science"},{"key":"1439_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135\u2013146.e9 (2018).","journal-title":"Cell"},{"key":"1439_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A. J., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1439_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.joca.2019.10.010","volume":"28","author":"OR Mahon","year":"2020","unstructured":"Mahon, O. R., Kelly, D. J., McCarthy, G. M. & Dunne, A. Osteoarthritis-associated basic calcium phosphate crystals alter immune cell metabolism and promote M1 macrophage polarization. Osteoarthr. Cartil. 28, 603\u2013612 (2020).","journal-title":"Osteoarthr. Cartil."},{"key":"1439_CR34","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1038\/s41598-021-98651-z","volume":"11","author":"K Koedderitzsch","year":"2021","unstructured":"Koedderitzsch, K., Zezina, E., Li, L., Herrmann, M. & Biesemann, N. TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A. Sci. Rep.\u00a011, 19385 (2021).","journal-title":"Sci. Rep."},{"key":"1439_CR35","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","volume":"188","author":"A Ziogas","year":"2025","unstructured":"Ziogas, A. et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell 188, 2992\u20133012.e16 (2025).","journal-title":"Cell"},{"key":"1439_CR36","first-page":"46","volume":"11","author":"EP Sabina","year":"2008","unstructured":"Sabina, E. P., Chandel, S. & Rasool, M. K. Inhibition of monosodium urate crystal-induced inflammation by withaferin A. J. Pharmacy Pharm. Sci. 11, 46\u201355 (2008).","journal-title":"J. Pharmacy Pharm. Sci."},{"key":"1439_CR37","doi-asserted-by":"crossref","first-page":"742\u2013745","DOI":"10.1136\/ard.43.5.742","volume":"43","author":"C Gobelet","year":"1984","unstructured":"Gobelet, C. & Gerster, J. C. Synovial fluid lactate levels in septic and non-septic arthritides. Ann. Rheum. Dis. 43, 742\u2013745 (1984).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/art.1780140407","volume":"14","author":"PS Treuhaft","year":"1971","unstructured":"Treuhaft, P. S. & McCarty, D. J. Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthr. Rheum. 14, 475\u2013484 (1971).","journal-title":"Arthr. Rheum."},{"key":"1439_CR39","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1093\/rheumatology\/keaf497","volume":"64","author":"J Zheng","year":"2025","unstructured":"Zheng, J. et al. SIRT3 inhibits fibroblast-like synoviocytes activation in rheumatoid arthritis through delactylation of H3K18. Rheumatology 64, 6387\u20136397 (2025).","journal-title":"Rheumatology"},{"key":"1439_CR40","doi-asserted-by":"crossref","first-page":"110489","DOI":"10.1016\/j.celrep.2022.110489","volume":"38","author":"I Cobo","year":"2022","unstructured":"Cobo, I. et al. Monosodium urate crystals regulate a unique JNK-dependent macrophage metabolic and inflammatory response. Cell Rep. 38, 110489 (2022).","journal-title":"Cell Rep."},{"key":"1439_CR41","doi-asserted-by":"crossref","first-page":"e1967","DOI":"10.1210\/clinem\/dgz306","volume":"105","author":"CDCC van der Heijden","year":"2020","unstructured":"van der Heijden, C. D. C. C. et al. Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 105, e1967\u2013e1980 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1439_CR42","doi-asserted-by":"crossref","first-page":"1671548","DOI":"10.3389\/fimmu.2025.1671548","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao, X. et al. Fatty acid metabolism in gouty arthritis: mechanisms to therapeutic targeting. Front. Immunol. 16, 1671548 (2025).","journal-title":"Front. Immunol."},{"key":"1439_CR43","doi-asserted-by":"crossref","first-page":"2420863","DOI":"10.1080\/07853890.2024.2420863","volume":"56","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Regulating lipid metabolism in osteoarthritis: a complex area with important future therapeutic potential. Ann. Med. 56, 2420863 (2024).","journal-title":"Ann. Med."},{"key":"1439_CR44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2025.10.004","volume":"47","author":"M Liu","year":"2026","unstructured":"Liu, M., Shen, X. & Xu, L. DNA methylation and histone modifications drive the trained immunity duration. Trends Immunol. 47, 61\u201376 (2026).","journal-title":"Trends Immunol."},{"key":"1439_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12110-2","volume":"7","author":"D Verma","year":"2017","unstructured":"Verma, D. et al. Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects. Sci. Rep. 7, 12305 (2017).","journal-title":"Sci. Rep."},{"key":"1439_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/annrheumdis-2012-201526","volume":"72","author":"K Nakano","year":"2013","unstructured":"Nakano, K., Whitaker, J. W., Boyle, D. L., Wang, W. & Firestein, G. S. DNA methylome signature in rheumatoid arthritis. Ann. Rheum. Dis. 72, 110\u2013117 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/gene.2011.45","volume":"12","author":"E Karouzakis","year":"2011","unstructured":"Karouzakis, E. et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun. 12, 643\u2013652 (2011).","journal-title":"Genes Immun."},{"key":"1439_CR48","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.23758","volume":"58","author":"CJ Nile","year":"2008","unstructured":"Nile, C. J., Read, R. C., Akil, M., Duff, G. W. & Wilson, A. G. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthr. Rheum. 58, 2686\u20132693 (2008).","journal-title":"Arthr. Rheum."},{"key":"1439_CR49","first-page":"370","volume":"129","author":"M Cie\u015bla","year":"2019","unstructured":"Cie\u015bla, M., Kolarz, B., Majdan, M. & Darmochwa\u0142-Kolarz, D. IRF5 promoter methylation as a new potential marker of rheumatoid arthritis. Pol. Arch. Intern. Med. 129, 370\u2013376 (2019).","journal-title":"Pol. Arch. Intern. Med."},{"key":"1439_CR50","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/aps.2011.98","volume":"32","author":"LH Fu","year":"2011","unstructured":"Fu, L. H. et al. Hypomethylation of proximal CpG motif of interleukin-10 promoter regulates its expression in human rheumatoid arthritis. Acta Pharmacol. Sin. 32, 1373 (2011).","journal-title":"Acta Pharmacol. Sin."},{"key":"1439_CR51","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1038\/s41598-017-08418-8","volume":"7","author":"A Takahashi","year":"2017","unstructured":"Takahashi, A. et al. DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes. Sci. Rep. 7, 7771 (2017).","journal-title":"Sci. Rep."},{"key":"1439_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep43592","volume":"7","author":"F Yang","year":"2017","unstructured":"Yang, F. et al. Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients. Sci. Rep. 7, 43592 (2017).","journal-title":"Sci. Rep."},{"key":"1439_CR53","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.joca.2015.02.168","volume":"23","author":"A Takahashi","year":"2015","unstructured":"Takahashi, A., de Andr\u00e9s, M. C., Hashimoto, K., Itoi, E. & Oreffo, R. O. C. Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis. Osteoarthr. Cartil. 23, 1946\u20131954 (2015).","journal-title":"Osteoarthr. Cartil."},{"key":"1439_CR54","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.18632\/aging.202353","volume":"13","author":"CC Tseng","year":"2021","unstructured":"Tseng, C. C. et al. Cell lineage-specific methylome and genome alterations in gout. Aging 13, 3843 (2021).","journal-title":"Aging"},{"key":"1439_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cei.13098","volume":"193","author":"S Alivernini","year":"2018","unstructured":"Alivernini, S. et al. Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells. Clin. Exp. Immunol. 193, 13\u201323 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"1439_CR56","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1439_CR57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/art.1780270811","volume":"27","author":"B Carnemolla","year":"1984","unstructured":"Carnemolla, B. et al. Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Arthr. Rheum. 27, 913\u2013921 (1984).","journal-title":"Arthr. Rheum."},{"key":"1439_CR58","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.4049\/jimmunol.174.9.5781","volume":"174","author":"JI Pulai","year":"2005","unstructured":"Pulai, J. I. et al. NF-\u03baB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J. Immunol. 174, 5781\u20135788 (2005).","journal-title":"J. Immunol."},{"key":"1439_CR59","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.24882","volume":"60","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto, K., Oreffo, R. O. C., Gibson, M. B., Goldring, M. B. & Roach, H. I. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthr. Rheum. 60, 3303\u20133313 (2009).","journal-title":"Arthr. Rheum."},{"key":"1439_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02892-y","volume":"9","author":"F Mizoguchi","year":"2018","unstructured":"Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).","journal-title":"Nat. Commun."},{"key":"1439_CR61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/annrheumdis-2011-200096","volume":"71","author":"M Chemel","year":"2012","unstructured":"Chemel, M. et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann. Rheum. Dis. 71, 150\u2013154 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR62","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.41792","volume":"73","author":"K Van Raemdonck","year":"2021","unstructured":"Van Raemdonck, K. et al. Interleukin-34 reprograms glycolytic and osteoclastic rheumatoid arthritis macrophages via syndecan 1 and macrophage colony-stimulating factor receptor. Arthr. Rheumatol. 73, 2003\u20132014 (2021).","journal-title":"Arthr. Rheumatol."},{"key":"1439_CR63","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.devcel.2025.02.001","volume":"60","author":"N Haacke","year":"2025","unstructured":"Haacke, N. et al. Innate immune training of osteoclastogenesis promotes inflammatory bone loss in mice. Dev. Cell 60, 1854\u20131870.e6 (2025).","journal-title":"Dev. Cell"},{"key":"1439_CR64","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/ard-2023-224774","volume":"83","author":"K Kachler","year":"2024","unstructured":"Kachler, K. et al. Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. Ann. Rheum. Dis. 83, 1691\u20131706 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR65","doi-asserted-by":"crossref","first-page":"112658","DOI":"10.1016\/j.celrep.2023.112658","volume":"42","author":"AV Ferreira","year":"2023","unstructured":"Ferreira, A. V. et al. Dimethyl itaconate induces long-term innate immune responses and confers protection against infection. Cell Rep. 42, 112658 (2023).","journal-title":"Cell Rep."},{"key":"1439_CR66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2018.09.003","volume":"29","author":"J Dom\u00ednguez-Andr\u00e9s","year":"2019","unstructured":"Dom\u00ednguez-Andr\u00e9s, J. et al. The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity. Cell Metab. 29, 211\u2013220.e5 (2019).","journal-title":"Cell Metab."},{"key":"1439_CR67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/ard-2022-223626","volume":"83","author":"S Cao","year":"2023","unstructured":"Cao, S. et al. L-arginine metabolism inhibits arthritis and inflammatory bone loss. Ann. Rheum. Dis. 83, 72\u201387 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR68","doi-asserted-by":"crossref","first-page":"e791","DOI":"10.1016\/S2665-9913(24)00122-X","volume":"6","author":"T Pascart","year":"2024","unstructured":"Pascart, T. et al. Calcium pyrophosphate deposition disease. Lancet Rheumatol. 6, e791\u2013e804 (2024).","journal-title":"Lancet Rheumatol."},{"key":"1439_CR69","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Fri\u0161\u010di\u0107","year":"2021","unstructured":"Fri\u0161\u010di\u0107, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002\u20131021.e10 (2021).","journal-title":"Immunity"},{"key":"1439_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77380-9","volume":"10","author":"U Gangishetti","year":"2020","unstructured":"Gangishetti, U. et al. Chronic exposure to TNF reprograms cell signaling pathways in fibroblast-like synoviocytes by establishing long-term inflammatory memory. Sci. Rep. 10, 20297 (2020).","journal-title":"Sci. Rep."},{"key":"1439_CR71","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.37834","volume":"65","author":"M Trenkmann","year":"2013","unstructured":"Trenkmann, M. et al. Tumor necrosis factor \u03b1-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-\u03baB signaling. Arthritis Rheum. 65, 916\u2013927 (2013).","journal-title":"Arthritis Rheum."},{"key":"1439_CR72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/art.30115","volume":"63","author":"J Stanczyk","year":"2011","unstructured":"Stanczyk, J. et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthr. Rheum. 63, 373\u2013381 (2011).","journal-title":"Arthr. Rheum."},{"key":"1439_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/srep20059","volume":"6","author":"N Mu","year":"2016","unstructured":"Mu, N. et al. A novel NF-\u03baB\/YY1\/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis. Sci. Rep. 6, 20059 (2016).","journal-title":"Sci. Rep."},{"key":"1439_CR74","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246\u2013251 (2019).","journal-title":"Nature"},{"key":"1439_CR75","doi-asserted-by":"crossref","first-page":"597512","DOI":"10.1155\/2015\/597512","volume":"2015","author":"JY Choe","year":"2015","unstructured":"Choe, J. Y., Park, K. Y. & Kim, S. K. Monosodium urate in the presence of RANKL promotes osteoclast formation through activation of c-Jun N-terminal kinase. Mediators Inflamm. 2015, 597512 (2015).","journal-title":"Mediators Inflamm."},{"key":"1439_CR76","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/rheumatology\/kev107","volume":"54","author":"CC Chang","year":"2015","unstructured":"Chang, C. C., Tsai, Y. H., Liu, Y., Lin, S. Y. & Liang, Y. C. Calcium-containing crystals enhance receptor activator of nuclear factor \u03baB ligand\/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways. Rheumatology 54, 1913\u20131922 (2015).","journal-title":"Rheumatology"},{"key":"1439_CR77","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3483","volume":"13","author":"SJ Lee","year":"2011","unstructured":"Lee, S. J. et al. Bone destruction by receptor activator of nuclear factor \u03baB ligand-expressing T cells in chronic gouty arthritis. Arthr. Res. Ther. 13, R164 (2011).","journal-title":"Arthr. Res. Ther."},{"key":"1439_CR78","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth, N., Gosling, A. L., Gaffo, A. & Abhishek, A. Gout. Lancet 397, 1843\u20131855 (2021).","journal-title":"Lancet"},{"key":"1439_CR79","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","volume":"73","author":"F Perez-Ruiz","year":"2014","unstructured":"Perez-Ruiz, F. et al. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann. Rheum. Dis. 73, 177\u2013182 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR80","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","volume":"62","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth, N. et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthr. Rheum. 62, 1549\u20131556 (2010).","journal-title":"Arthr. Rheum."},{"key":"1439_CR81","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ard.2025.09.003","volume":"84","author":"H Xu","year":"2025","unstructured":"Xu, H. et al. Deconstruction of tophi and synovium defines SPP1+ macrophages involved in extracellular matrix remodelling in gout. Ann. Rheum. Dis. 84, 2088\u20132102 (2025).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/art.41515","volume":"73","author":"HK Ea","year":"2021","unstructured":"Ea, H. K. et al. Calcium pyrophosphate dihydrate crystal deposition in gouty tophi. Arthr. Rheumatol. 73, 324\u2013329 (2021).","journal-title":"Arthr. Rheumatol."},{"key":"1439_CR83","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/art.23488","volume":"58","author":"N Dalbeth","year":"2008","unstructured":"Dalbeth, N. et al. Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthr. Rheum. 58, 1854\u20131865 (2008).","journal-title":"Arthr. Rheum."},{"key":"1439_CR84","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jbspin.2004.12.010","volume":"72","author":"R Liu-Bryan","year":"2005","unstructured":"Liu-Bryan, R. & Liot\u00e9, F. Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Jt Bone Spine 72, 295\u2013302 (2005).","journal-title":"Jt Bone Spine"},{"key":"1439_CR85","doi-asserted-by":"crossref","first-page":"29265","DOI":"10.3390\/ijms161226164","volume":"16","author":"HS Hwang","year":"2015","unstructured":"Hwang, H. S., Yang, C. M., Park, S. J. & Kim, H. A. Monosodium urate crystal-induced chondrocyte death via autophagic process. Int. J. Mol. Sci. 16, 29265\u201329277 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"1439_CR86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","volume":"16","author":"LAB Joosten","year":"2020","unstructured":"Joosten, L. A. B., Cri\u015fan, T. O., Bjornstad, P. & Johnson, R. J. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat. Rev. Rheumatol. 16, 75\u201386 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1439_CR87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fmed.2020.607186","volume":"7","author":"C Lambert","year":"2021","unstructured":"Lambert, C. et al. The damage-associated molecular patterns (DAMPs) as potential targets to treat osteoarthritis: perspectives from a review of the literature. Front. Med. 7, 11\u201313 (2021).","journal-title":"Front. Med."},{"key":"1439_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33779-z","volume":"8","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Chromatin accessibility landscape of articular knee cartilage reveals aberrant enhancer regulation in osteoarthritis. Sci. Rep. 8, 15499 (2018).","journal-title":"Sci. Rep."},{"key":"1439_CR89","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/art.38713","volume":"66","author":"MD Rushton","year":"2014","unstructured":"Rushton, M. D. et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthr. Rheumatol. 66, 2450\u20132460 (2014).","journal-title":"Arthr. Rheumatol."},{"key":"1439_CR90","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.joca.2005.03.008","volume":"13","author":"C Sanchez","year":"2005","unstructured":"Sanchez, C. et al. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1\u03b2 and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthr. Cartil. 13, 979\u2013987 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"1439_CR91","first-page":"279","volume":"71","author":"HM van Beuningen","year":"1994","unstructured":"van Beuningen, H. M., van der Kraan, P. M., Arntz, O. J. & van den Berg, W. B. Transforming growth factor-\u03b21 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 71, 279\u2013290 (1994).","journal-title":"Lab. Invest."},{"key":"1439_CR92","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s12015-024-10711-9","volume":"20","author":"NR Rahmani","year":"2024","unstructured":"Rahmani, N. R. et al. Trained innate immunity modulates osteoblast and osteoclast differentiation. Stem Cell Rev. Rep. 20, 1121\u20131134 (2024).","journal-title":"Stem Cell Rev. Rep."},{"key":"1439_CR93","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2008-10-184754","volume":"114","author":"MJ Christopher","year":"2009","unstructured":"Christopher, M. J., Liu, F., Hilton, M. J., Long, F. & Link, D. C. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 114, 1331\u20131339 (2009).","journal-title":"Blood"},{"key":"1439_CR94","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41590-019-0402-5","volume":"20","author":"T Chavakis","year":"2019","unstructured":"Chavakis, T., Mitroulis, I. & Hajishengallis, G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat. Immunol. 20, 802\u2013811 (2019).","journal-title":"Nat. Immunol."},{"key":"1439_CR95","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/art.43042","volume":"77","author":"R Kuley","year":"2025","unstructured":"Kuley, R. et al. Neutrophil activation markers and rheumatoid arthritis treatment response to the JAK1\/2 inhibitor baricitinib. Arthr. Rheumatol. 77, 395\u2013404 (2025).","journal-title":"Arthr. Rheumatol."},{"key":"1439_CR96","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J. S., Aletaha, D. & McInnes, I. B. Rheumatoid arthritis. Lancet 388, 2023\u20132038 (2016).","journal-title":"Lancet"},{"key":"1439_CR97","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/rheumatology\/keaa220","volume":"59","author":"RS Thwaites","year":"2020","unstructured":"Thwaites, R. S. et al. TLR1\/2 and 5 induce elevated cytokine levels from rheumatoid arthritis monocytes independent of ACPA or RF autoantibody status. Rheumatology 59, 3533\u20133539 (2020).","journal-title":"Rheumatology"},{"key":"1439_CR98","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/art.20166","volume":"50","author":"A Cross","year":"2004","unstructured":"Cross, A., Edwards, S. W., Bucknall, R. C. & Moots, R. J. Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthr. Rheum. 50, 1430\u20131436 (2004).","journal-title":"Arthr. Rheum."},{"key":"1439_CR99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2019.05.008","volume":"49","author":"D Boulos","year":"2019","unstructured":"Boulos, D. et al. The neutrophil\u2013lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy. Semin. Arthr. Rheum. 49, 373\u2013376 (2019).","journal-title":"Semin. Arthr. Rheum."},{"key":"1439_CR100","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.175.4.2579","volume":"175","author":"E Jimenez-Boj","year":"2005","unstructured":"Jimenez-Boj, E. et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J. Immunol. 175, 2579\u20132588 (2005).","journal-title":"J. Immunol."},{"key":"1439_CR101","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13075-017-1483-x","volume":"19","author":"E Kuca-Warnawin","year":"2017","unstructured":"Kuca-Warnawin, E. et al. Rheumatoid arthritis bone marrow environment supports Th17 response. Arthritis Res. Ther. 19, 274 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"1439_CR102","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110827","volume":"27","author":"P Chatterjee","year":"2024","unstructured":"Chatterjee, P. et al. Single-cell transcriptome and crosstalk analysis reveals immune alterations and key pathways in the bone marrow of knee OA patients. iScience 27, 110827 (2024).","journal-title":"iScience"},{"key":"1439_CR103","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","volume":"144","author":"L Edgar","year":"2021","unstructured":"Edgar, L. et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis. Circulation 144, 961\u2013982 (2021).","journal-title":"Circulation"},{"key":"1439_CR104","doi-asserted-by":"publisher","first-page":"457\u2013465","DOI":"10.1038\/s41586-024-08165-7","volume":"636","author":"LC Hinte","year":"2024","unstructured":"Hinte, L. C. et al. Adipose tissue retains an epigenetic memory of obesity after weight loss. Nature 636, 457\u2013465 (2024).","journal-title":"Nature"},{"key":"1439_CR105","first-page":"945","volume":"83","author":"HK Ea","year":"2024","unstructured":"Ea, H. K. et al. Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker. Ann. Rheum. Dis. 83, 945\u2013956 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR106","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-021-08899-6","volume":"64","author":"T Fulop","year":"2023","unstructured":"Fulop, T. et al. Immunology of aging: the birth of inflammaging. Clin. Rev. Allergy Immunol. 64, 109\u2013122 (2023).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"1439_CR107","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-07693-6","volume":"634","author":"JR Lavillegrand","year":"2024","unstructured":"Lavillegrand, J. R. et al. Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming. Nature 634, 447\u2013456 (2024).","journal-title":"Nature"},{"key":"1439_CR108","volume":"1","author":"K Cai","year":"2022","unstructured":"Cai, K. et al. Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand. BMJ Med. 1, e000081 (2022).","journal-title":"BMJ Med."},{"key":"1439_CR109","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12603-017-0941-0","volume":"22","author":"N Veronese","year":"2018","unstructured":"Veronese, N. et al. Osteoarthritis increases the risk of cardiovascular disease: data from the osteoarthritis initiative. J. Nutr. Health Aging 22, 371\u2013376 (2018).","journal-title":"J. Nutr. Health Aging"},{"key":"1439_CR110","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","volume":"3","author":"A Rheumatology","year":"2021","unstructured":"Rheumatology, A. et al. Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol. 3, e58\u2013e70 (2021).","journal-title":"Lancet Rheumatol."},{"key":"1439_CR111","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/annrheumdis-2022-222387","volume":"81","author":"SK Tedeschi","year":"2022","unstructured":"Tedeschi, S. K., Huang, W., Yoshida, K. & Solomon, D. H. Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis. Ann. Rheum. Dis. 81, 1323\u20131329 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR112","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel, S. E. & Michaud, K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthr. Res. Ther. 11, 229 (2009).","journal-title":"Arthr. Res. Ther."},{"key":"1439_CR113","doi-asserted-by":"crossref","first-page":"d8190","DOI":"10.1136\/bmj.d8190","volume":"344","author":"HK Choi","year":"2012","unstructured":"Choi, H. K., Soriano, L. C., Zhang, Y. & Rodriguez, L. A. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 344, d8190 (2012).","journal-title":"BMJ"},{"key":"1439_CR114","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCRESAHA.119.315800","volume":"127","author":"CDCC Van Der Heijden","year":"2020","unstructured":"Van Der Heijden, C. D. C. C. et al. Catecholamines induce trained immunity in monocytes in vitro and in vivo. Circ. Res. 127, 269\u2013283 (2020).","journal-title":"Circ. Res."},{"key":"1439_CR115","first-page":"317","volume":"116","author":"CDCC Van Der Heijden","year":"2020","unstructured":"Van Der Heijden, C. D. C. C. et al. Aldosterone induces trained immunity: the role of fatty acid synthesis. Cardiovasc. Res. 116, 317\u2013328 (2020).","journal-title":"Cardiovasc. Res."},{"key":"1439_CR116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41413-023-00301-9","volume":"11","author":"G Wei","year":"2023","unstructured":"Wei, G. et al. Risk of metabolic abnormalities in osteoarthritis: a new perspective to understand its pathological mechanisms. Bone Res. 11, 63 (2023).","journal-title":"Bone Res."},{"key":"1439_CR117","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12700","volume":"15","author":"N Jamal","year":"2025","unstructured":"Jamal, N., Hollabaugh, W., Scott, L. & Takkouche, S. Unravelling the ties that bind: the intersection of obesity, osteoarthritis, and inflammatory pathways with emphasis on glucagon-like peptide-1 agonists. Clin. Obes. 15, e12700 (2025).","journal-title":"Clin. Obes."},{"key":"1439_CR118","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00256-020-03550-5","volume":"50","author":"T Kanthawang","year":"2021","unstructured":"Kanthawang, T. et al. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: data from the osteoarthritis initiative. Skelet. Radiol. 50, 217\u2013229 (2021).","journal-title":"Skelet. Radiol."},{"key":"1439_CR119","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.joca.2020.02.837","volume":"28","author":"CL Daugaard","year":"2020","unstructured":"Daugaard, C. L. et al. The impact of a significant weight loss on inflammation assessed on DCE-MRI and static MRI in knee osteoarthritis: a prospective cohort study. Osteoarthr. Cartil. 28, 766\u2013773 (2020).","journal-title":"Osteoarthr. Cartil."},{"key":"1439_CR120","doi-asserted-by":"crossref","first-page":"ehab724.3438","DOI":"10.1093\/eurheartj\/ehab724.3438","volume":"42","author":"J Van Tuijl","year":"2021","unstructured":"Van Tuijl, J. et al. Adipose tissue induces trained innate immunity in patients with obesity. Eur. Heart J. 42, ehab724.3438 (2021).","journal-title":"Eur. Heart J."},{"key":"1439_CR121","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.76744","volume":"11","author":"AL Seufert","year":"2022","unstructured":"Seufert, A. L. et al. Enriched dietary saturated fatty acids induce trained immunity via ceramide production that enhances severity of endotoxemia and clearance of infection. eLife 11, e76744 (2022).","journal-title":"eLife"},{"key":"1439_CR122","doi-asserted-by":"crossref","first-page":"116884","DOI":"10.1016\/j.bone.2023.116884","volume":"176","author":"R Pal","year":"2023","unstructured":"Pal, R. & Bhadada, S. K. AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: a narrative review. Bone 176, 116884 (2023).","journal-title":"Bone"},{"key":"1439_CR123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1302\/2046-3758.115.BJR-2021-0334.R1","volume":"11","author":"CP He","year":"2022","unstructured":"He, C. P. et al. The role of AGEs in pathogenesis of cartilage destruction in osteoarthritis. Bone Jt Res. 11, 292\u2013300 (2022).","journal-title":"Bone Jt Res."},{"key":"1439_CR124","doi-asserted-by":"crossref","first-page":"C456","DOI":"10.1152\/ajpcell.00153.2025","volume":"329","author":"A Grigorescu","year":"2025","unstructured":"Grigorescu, A., Riza, A. L., Streata, I. & Netea, M. G. Metabolic dysregulation of trained immunity in immune aging and the impact of dietary patterns. Am. J. Physiol. Cell Physiol. 329, C456\u2013C470 (2025).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1439_CR125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).","journal-title":"PLoS Biol."},{"key":"1439_CR126","first-page":"CD009993","volume":"2014","author":"F Sivera","year":"2014","unstructured":"Sivera, F., Wechalekar, M. D., Andr\u00e9s, M., Buchbinder, R. & Carmona, L. Interleukin-1 inhibitors for acute gout. Cochrane Database Syst. Rev. 2014, CD009993 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1439_CR127","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41584-024-01169-7","volume":"20","author":"V Konzett","year":"2024","unstructured":"Konzett, V. & Aletaha, D. Management strategies in rheumatoid arthritis. Nat. Rev. Rheumatol. 20, 760\u2013769 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1439_CR128","first-page":"1001","volume":"38","author":"E Cipolletta","year":"2020","unstructured":"Cipolletta, E. et al. Biologics in the treatment of calcium pyrophosphate deposition disease: systematic literature review. Clin. Exp. Rheumatol. 38, 1001\u20131007 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1439_CR129","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/rheumatology\/key131","volume":"57","author":"MSM Persson","year":"2018","unstructured":"Persson, M. S. M., Sarmanova, A., Doherty, M. & Zhang, W. Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials. Rheumatology 57, 1830\u20131837 (2018).","journal-title":"Rheumatology"},{"key":"1439_CR130","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41588-023-01598-2","volume":"56","author":"ET Fok","year":"2024","unstructured":"Fok, E. T. et al. A chromatin-regulated biphasic circuit coordinates IL-1\u03b2-mediated inflammation. Nat. Genet. 56, 85\u201399 (2024).","journal-title":"Nat. Genet."},{"key":"1439_CR131","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588\u2013606 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1439_CR132","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","volume":"19","author":"T kodi","year":"2024","unstructured":"kodi, T., Sankhe, R., Gopinathan, A., Nandakumar, K. & Kishore, A. New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation. J. Neuroimmune Pharmacol. 19, 7 (2024).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1439_CR133","doi-asserted-by":"crossref","first-page":"1624770","DOI":"10.3389\/fimmu.2025.1624770","volume":"16","author":"MV Pinz\u00f3n-Fern\u00e1ndez","year":"2025","unstructured":"Pinz\u00f3n-Fern\u00e1ndez, M. V. et al. NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease. Front. Immunol. 16, 1624770 (2025).","journal-title":"Front. Immunol."},{"key":"1439_CR134","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"KC Barnett","year":"2023","unstructured":"Barnett, K. C., Li, S., Liang, K. & Ting, J. P. Y. A 360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell 186, 2288\u20132312 (2023).","journal-title":"Cell"},{"key":"1439_CR135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"A Christ","year":"2018","unstructured":"Christ, A. et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell 172, 162\u2013175.e14 (2018).","journal-title":"Cell"},{"key":"1439_CR136","doi-asserted-by":"crossref","first-page":"eabe2933","DOI":"10.1126\/sciimmunol.abe2933","volume":"6","author":"GM Ren","year":"2021","unstructured":"Ren, G. M. et al. Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases. Sci. Immunol. 6, eabe2933 (2021).","journal-title":"Sci. Immunol."},{"key":"1439_CR137","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1126\/sciadv.adq4266","volume":"11","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z. et al. Isocyanic acid-mediated NLRP3 carbamoylation reduces NLRP3\u2013NEK7 interaction and limits inflammasome activation. Sci. Adv. 11, 4266 (2025).","journal-title":"Sci. Adv."},{"key":"1439_CR138","volume":"11","author":"YT Li","year":"2025","unstructured":"Li, Y. T. et al. USP13 stabilizes NLRP3 to facilitate inflammasome activation by preventing TRIM31-mediated NLRP3 ubiquitination and degradation. Sci. Adv. 11, eadx3827 (2025).","journal-title":"Sci. Adv."},{"key":"1439_CR139","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/annrheumdis-2014-206258","volume":"75","author":"MC Cleophas","year":"2016","unstructured":"Cleophas, M. C. et al. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann. Rheum. Dis. 75, 593\u2013600 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR140","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"M Viola Kl\u00fcck","year":"2020","unstructured":"Viola Kl\u00fcck, M. et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2, e270\u2013e280 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1439_CR141","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti, C. et al. OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc. Natl Acad. Sci. USA 115, E1530\u2013E1539 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1439_CR142","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","volume":"49","author":"MS Braza","year":"2018","unstructured":"Braza, M. S. et al. Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance. Immunity 49, 819 (2018).","journal-title":"Immunity"},{"key":"1439_CR143","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.accounts.7b00339","volume":"51","author":"WJM Mulder","year":"2018","unstructured":"Mulder, W. J. M. et al. High-density lipoprotein nanobiologics for precision medicine. Acc. Chem. Res. 51, 127\u2013137 (2018).","journal-title":"Acc. Chem. Res."},{"key":"1439_CR144","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","volume":"183","author":"B Priem","year":"2020","unstructured":"Priem, B. et al. Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition. Cell 183, 786\u2013801.e19 (2020).","journal-title":"Cell"},{"key":"1439_CR145","doi-asserted-by":"crossref","first-page":"107575","DOI":"10.1016\/j.intimp.2021.107575","volume":"95","author":"MS Abdallah","year":"2021","unstructured":"Abdallah, M. S. et al. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Int. Immunopharmacol. 95, 107575 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"1439_CR146","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/ard-2024-225652","volume":"83","author":"J Marrugo","year":"2024","unstructured":"Marrugo, J. et al. Gout risk in adults with pre-diabetes initiating metformin. Ann. Rheum. Dis. 83, 1368\u20131374 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR147","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/jama.2025.3471","volume":"333","author":"F Pan","year":"2025","unstructured":"Pan, F. et al. Metformin for knee osteoarthritis in patients with overweight or obesity: a randomized clinical trial. JAMA 333, 1804\u20131812 (2025).","journal-title":"JAMA"},{"key":"1439_CR148","volume":"13","author":"CH Lu","year":"2018","unstructured":"Lu, C. H. et al. Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: a nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE 13, e0191242 (2018).","journal-title":"PLoS ONE"},{"key":"1439_CR149","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41927-022-00261-3","volume":"6","author":"F Veenstra","year":"2022","unstructured":"Veenstra, F. et al. Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort study. BMC Rheumatol. 6, 27 (2022).","journal-title":"BMC Rheumatol."},{"key":"1439_CR150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/annrheumdis-2018-214656","volume":"78","author":"N Vazirpanah","year":"2019","unstructured":"Vazirpanah, N. et al. MTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy? Ann. Rheum. Dis. 78, 663\u2013671 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1439_CR151","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1093\/nar\/gkae1105","volume":"52","author":"RL Tiedemann","year":"2024","unstructured":"Tiedemann, R. L. et al. UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation. Nucleic Acids Res. 52, 13733 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1439_CR152","doi-asserted-by":"crossref","first-page":"110644","DOI":"10.1016\/j.intimp.2023.110644","volume":"122","author":"M Vijaykrishnaraj","year":"2023","unstructured":"Vijaykrishnaraj, M. et al. Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis. Int. Immunopharmacol. 122, 110644 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"1439_CR153","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/ibd\/izz317","volume":"26","author":"JW Lee","year":"2020","unstructured":"Lee, J. W. et al. Novel histone deacetylase 6 inhibitor CKD-506 inhibits NF-\u03baB signaling in intestinal epithelial cells and macrophages and ameliorates acute and chronic murine colitis. Inflamm. Bowel Dis. 26, 852\u2013862 (2020).","journal-title":"Inflamm. Bowel Dis."},{"key":"1439_CR154","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1248\/bpb.b22-00321","volume":"45","author":"W Zhe","year":"2022","unstructured":"Zhe, W. et al. A novel HDAC1-selective inhibitor attenuates autoimmune arthritis by inhibiting inflammatory cytokine production. Biol. Pharm. Bull. 45, 1364\u20131372 (2022).","journal-title":"Biol. Pharm. Bull."},{"key":"1439_CR155","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41588-018-0298-2","volume":"51","author":"S Fanucchi","year":"2019","unstructured":"Fanucchi, S. et al. Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments. Nat. Genet. 51, 138\u2013150 (2019).","journal-title":"Nat. Genet."},{"key":"1439_CR156","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle, M., El-Daly, S. M., Fabbri, M. & Calin, G. A. Noncoding RNA therapeutics \u2014 challenges and potential solutions. Nat. Rev. Drug Discov. 20, 629\u2013651 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1439_CR157","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev-immunol-101721-035114","volume":"43","author":"MM Mhlanga","year":"2025","unstructured":"Mhlanga, M. M., Fanucchi, S., Ozturk, M. & Divangahi, M. Cellular and molecular mechanisms of innate memory responses. Annu. Rev. Immunol. 43, 615\u2013640 (2025).","journal-title":"Annu. Rev. Immunol."},{"key":"1439_CR158","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cmet.2020.07.016","volume":"32","author":"A Hooftman","year":"2020","unstructured":"Hooftman, A. et al. The Immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 32, 468\u2013478.e7 (2020).","journal-title":"Cell Metab."},{"key":"1439_CR159","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00018-025-05699-5","volume":"82","author":"C Molina-Lopez","year":"2025","unstructured":"Molina-Lopez, C., Hurtado-Navarro, L., O\u2019Neill, L. A. J. & Pelegrin, P. 4-octyl itaconate reduces human NLRP3 inflammasome constitutive activation with the cryopyrin-associated periodic syndrome p.R262W, p.D305N and p.T350M variants. Cell. Mol. Life Sci. 82, 209 (2025).","journal-title":"Cell. Mol. Life Sci."},{"key":"1439_CR160","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm, Y. H. et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263\u2013269 (2015).","journal-title":"Nat. Med."},{"key":"1439_CR161","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg, E. L. et al. \u03b2-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 18, 2077\u20132087 (2017).","journal-title":"Cell Rep."},{"key":"1439_CR162","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41590-021-00867-8","volume":"22","author":"GS Temba","year":"2021","unstructured":"Temba, G. S. et al. Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes. Nat. Immunol. 22, 287\u2013300 (2021).","journal-title":"Nat. Immunol."},{"key":"1439_CR163","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1172\/JCI83260","volume":"125","author":"J Traba","year":"2015","unstructured":"Traba, J. et al. Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects. J. Clin. Invest. 125, 4592\u20134600 (2015).","journal-title":"J. Clin. Invest."},{"key":"1439_CR164","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajcnut.2022.10.015","volume":"117","author":"CH Rhodes","year":"2023","unstructured":"Rhodes, C. H. et al. Human fasting modulates macrophage function and upregulates multiple bioactive metabolites that extend lifespan in Caenorhabditis elegans: a pilot clinical study. Am. J. Clin. Nutr. 117, 286\u2013297 (2023).","journal-title":"Am. J. Clin. Nutr."},{"key":"1439_CR165","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","volume":"184","author":"HC Wastyk","year":"2021","unstructured":"Wastyk, H. C. et al. Gut microbiota-targeted diets modulate human immune status. Cell 184, 4137 (2021).","journal-title":"Cell"},{"key":"1439_CR166","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/s41591-025-03602-0","volume":"31","author":"GS Temba","year":"2025","unstructured":"Temba, G. S. et al. Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial. Nat. Med. 31, 1698\u20131711 (2025).","journal-title":"Nat. Med."},{"key":"1439_CR167","doi-asserted-by":"crossref","first-page":"113006","DOI":"10.1016\/j.celrep.2023.113006","volume":"42","author":"M von Wulffen","year":"2023","unstructured":"von Wulffen, M. et al. S100A8\/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Rep. 42, 113006 (2023).","journal-title":"Cell Rep."},{"key":"1439_CR168","doi-asserted-by":"crossref","first-page":"448165","DOI":"10.3389\/fimmu.2019.00791","volume":"10","author":"M Neidhart","year":"2019","unstructured":"Neidhart, M. et al. Oligomeric S100A4 is associated with monocyte innate immune memory and bypass of tolerance to subsequent stimulation with lipopolysaccharides. Front. Immunol. 10, 448165 (2019).","journal-title":"Front. Immunol."},{"key":"1439_CR169","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s42003-025-08303-5","volume":"8","author":"H Lin","year":"2025","unstructured":"Lin, H. et al. Cathepsin B-dependent glycolysis contributes to reduced renal uric acid excretion in hyperuricemia. Commun. Biol. 8, 845 (2025).","journal-title":"Commun. Biol."},{"key":"1439_CR170","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","volume":"94","author":"YJ Choi","year":"2014","unstructured":"Choi, Y. J. et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab. Invest. 94, 1114\u20131125 (2014).","journal-title":"Lab. Invest."},{"key":"1439_CR171","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","volume":"39","author":"Y Qiao","year":"2013","unstructured":"Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-\u03b3-induced chromatin remodeling and Toll-like receptor signaling. Immunity 39, 454\u2013469 (2013).","journal-title":"Immunity"},{"key":"1439_CR172","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/art.34544","volume":"64","author":"RA Gordon","year":"2012","unstructured":"Gordon, R. A., Grigoriev, G., Lee, A., Kalliolias, G. D. & Ivashkiv, L. B. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor \u03b1 and counter-regulated by the synovial fluid microenvironment. Arthr. Rheum. 64, 3119\u20133128 (2012).","journal-title":"Arthr. Rheum."},{"key":"1439_CR173","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3389\/fimmu.2016.00680","volume":"7","author":"F Borriello","year":"2017","unstructured":"Borriello, F. et al. GM-CSF and IL-3 modulate human monocyte TNF-\u03b1 production and renewal in in vitro models of trained immunity. Front. Immunol. 7, 680 (2017).","journal-title":"Front. Immunol."},{"key":"1439_CR174","first-page":"132","volume":"90","author":"D Shishkova","year":"2025","unstructured":"Shishkova, D. et al. Physiological concentrations of calciprotein particles trigger activation and pro-inflammatory response in endothelial cells and monocytes. Biochem 90, 132\u2013160 (2025).","journal-title":"Biochem"},{"key":"1439_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17749-6","volume":"11","author":"E J\u00e4ger","year":"2020","unstructured":"J\u00e4ger, E. et al. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis. Nat. Commun. 11, 4243 (2020).","journal-title":"Nat. Commun."},{"key":"1439_CR176","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","volume":"195","author":"C Termeer","year":"2002","unstructured":"Termeer, C. et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195, 99\u2013111 (2002).","journal-title":"J. Exp. Med."},{"key":"1439_CR177","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jor.20716","volume":"27","author":"AR Klatt","year":"2009","unstructured":"Klatt, A. R. et al. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPS in primary human chondrocytes. J. Orthop. Res. 27, 65\u201370 (2009).","journal-title":"J. Orthop. Res."},{"key":"1439_CR178","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","volume":"18","author":"L Liu","year":"2016","unstructured":"Liu, L. et al. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout. Arthr. Res. Ther. 18, 268 (2016).","journal-title":"Arthr. Res. Ther."},{"key":"1439_CR179","doi-asserted-by":"crossref","first-page":"108955","DOI":"10.1016\/j.celrep.2021.108955","volume":"35","author":"G Cavalli","year":"2021","unstructured":"Cavalli, G. et al. The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity. Cell Rep. 35, 108955 (2021).","journal-title":"Cell Rep."},{"key":"1439_CR180","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/19476035251372304","volume":"17","author":"EW van Geffen","year":"2026","unstructured":"van Geffen, E. W. et al. Interleukin-37 ameliorates articular cartilage damage in two murine models of osteoarthritis. Cartilage 17, 808\u2013820 (2026).","journal-title":"Cartilage"},{"key":"1439_CR181","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013257 (2015).","journal-title":"Nat. Med."},{"key":"1439_CR182","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.coi.2006.03.020","volume":"18","author":"V Kalia","year":"2006","unstructured":"Kalia, V., Sarkar, S., Gourley, T. S., Rouse, B. T. & Ahmed, R. Differentiation of memory B and T cells. Curr. Opin. Immunol. 18, 255\u2013264 (2006).","journal-title":"Curr. Opin. Immunol."},{"key":"1439_CR183","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","volume":"33","author":"F Sallusto","year":"2010","unstructured":"Sallusto, F., Lanzavecchia, A., Araki, K. & Ahmed, R. From vaccines to memory and back. Immunity 33, 451\u2013463 (2010).","journal-title":"Immunity"},{"key":"1439_CR184","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","volume":"9","author":"MG Netea","year":"2011","unstructured":"Netea, M. G., Quintin, J. & Van Der Meer, J. W. M. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355\u2013361 (2011).","journal-title":"Cell Host Microbe"},{"key":"1439_CR185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","volume":"34","author":"CS Benn","year":"2013","unstructured":"Benn, C. S., Netea, M. G., Selin, L. K. & Aaby, P. A small jab \u2014 a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 34, 431\u2013439 (2013).","journal-title":"Trends Immunol."},{"key":"1439_CR186","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02681218880000401","volume":"26","author":"F Bistoni","year":"1988","unstructured":"Bistoni, F. et al. Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J. Med. Vet. Mycol. 26, 285\u2013299 (1988).","journal-title":"J. Med. Vet. Mycol."},{"key":"1439_CR187","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/iai.51.2.668-674.1986","volume":"51","author":"F Bistoni","year":"1986","unstructured":"Bistoni, F. et al. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51, 668\u2013674 (1986).","journal-title":"Infect. Immun."},{"key":"1439_CR188","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41577-025-01132-x","volume":"25","author":"G Hajishengallis","year":"2025","unstructured":"Hajishengallis, G., Netea, M. G. & Chavakis, T. Trained immunity in chronic inflammatory diseases and cancer. Nat. Rev. Immunol. 25, 497\u2013514 (2025).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01439-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01439-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01439-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:42:07Z","timestamp":1791826927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-026-01439-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":188,"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1038\/s41584-026-01439-6","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"4 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.K., S.N. and C.L. declare no competing interests. H.K.E. is the scientific founder of RheumaCare. L.A.B.J. is the scientific founder of Trained Therapeutix.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}